disease_target_phase,primary_use_case,assay_aim,assay_target,target_analyte,drug_resistance_target,other_drug_resistance_target,validated_sample_types,other_validated_sample_type,submission_id,submission_title,manufacturer,country,region,stage_of_development,regulatory_status,other_regulatory_status,target_pathogen,planned_market_entry,type_of_technology,technology_principle,test_format,instrument_requirement,lab_vs_poc,readout_technology,resistance_marker,other_test_format,level_of_automation,self_testing_self_collection,time_to_results_excl_prep,test_to_be_listed_on_finds_web_page,data_to_be_published_on_finds_web_page,target_patient_group,type_data_source,study_type,performance_submission_title,sensitivity,sensitivity_ci_low,sensitivity_ci_up,specificity,specificity_ci_low,specificity_ci_up,total_number_samples,sample_type,number_positive_samples,number_negative_samples,permalink
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (HIV+ patients),42,31,55,91,85,95,3449,Urine,1277,2172,https://globalpointofcare.abbott/en/index.html
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (overall symptomatic HIV+ patients),42,31,55,91,85,95,3449,Urine,1277,2172,https://globalpointofcare.abbott/en/index.html
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (overall unselected HIV+ patients),35,22,50,95,89,98,3365,Urine,432,2933,https://globalpointofcare.abbott/en/index.html
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (symptomatic HIV+ inpatient),52,40,64,87,78,93,2253,Urine,868,1385,https://globalpointofcare.abbott/en/index.html
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (symptomatic HIV+ outpatient),29,17,47,96,91,99,1196,Urine,409,787,https://globalpointofcare.abbott/en/index.html
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (unselected HIV+ inpatient),62,41,83,84,48,96,537,Urine,159,378,https://globalpointofcare.abbott/en/index.html
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (unselected HIV+ outpatient),31,18,47,95,87,99,2828,Urine,273,2555,https://globalpointofcare.abbott/en/index.html
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,NA,a2r69000007lb91,IP-10 IGRA LF,R-Biopharm AG,Germany,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,IGRA,Rapid diagnostic test (strip or cassette),No instrumentation is required,near Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://r-biopharm.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,heprin,a2r69000007lbFH,IP-10 IGRA ELISA,R-Biopharm AG,Germany,European Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://r-biopharm.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Plasma,NA,a2r69000007lbFL,STANDARD E TB-Feron ELISA,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD; Korea MFDS,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,100,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://sdbiosensor.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Unknown,Isoniazid; Pyrazinamide; Rifampicin,NA,Unknown,NA,a2r69000007lbEo,INFINITIMTB Assay,Autogenomics,United States,Region of the Americas,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,Lab-based,Fluorescence,katG; pncA; rpoB,microarray chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://autogenomics.com/?q=node/42
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Unknown,Amikacin; Fluoroquinolone; Isoniazid; Kanamycin; Rifampicin,NA,Sputum,NA,a2r69000007lbF6,IRON qPCR RFIA kit (preXDR-TB),Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Unknown,NA,Fully automated (including sample preparation),Intended for professional use only,60,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://bioneer.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection (against AFB smear positive subjects ),99.7,98.4,99.9,98.5,91.9,99.7,417,Sputum,351,66,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection (against AFB smear negative subjects ),76.1,67.6,82.9,98.8,97.5,99.4,679,Sputum,117,562,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,85,82,88,98,97,98,37237,Sputum,NA,NA,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,TB detection from sputum  (smear positive),98,97,98,NA,NA,NA,18275,Sputum,NA,NA,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear negative),67,62,72,98,98,99,18962,Sputum,NA,NA,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,96,94,97,98,98,99,8020,Sputum,NA,NA,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb95,Xpert MTB/RIF Ultra,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,90,84,94,96,93,97,2654,Sputum,NA,NA,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb95,Xpert MTB/RIF Ultra,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,94.9,88.9,97.9,99.1,97.7,99.8,930,Sputum,NA,NA,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,95.2,92.9,96.8,95.6,90.1,98.1,596,Sputum,464,132,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,FLQ detection from sputum,94.5,90.7,96.9,95.2,92.5,96.9,594,Sputum,226,368,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,AMK detection from sputum,87.7,77.5,93.6,98.5,97,99.2,593,Sputum,65,528,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,KAN detection from sputum,93.7,89,96.4,92.4,89.4,94.6,594,Sputum,195,399,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,CAP detection from sputum,75.4,64,84,99.6,98.6,99.9,595,Sputum,54,541,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,ETH detection from sputum,55,49.5,60.3,93.8,90.3,96.1,597,Sputum,194,403,https://cepheid.com
Latent,Triage/Screening,ID,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Whole Blood,NA,a2r69000007lbFE,T-SPOT.TB,Oxford Immunotec Limited,United Kingdom,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Unspecified,A proprietary/new instrument is optional,Lab-based,Colorimetric,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://oxfordimmunotec.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110; MTB pab gene,Not applicable,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lbLJ,Abbott RealTime MTB,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,96.2,90.2,98.6,97.1,93.7,98.7,4858,Sputum,NA,NA,https://abbottmolecular.com/home.html
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF resistance from sputum,94.8,88.3,98.3,100,97,100,216,Sputum,91,125,https://abbottmolecular.com/home.html
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH resistance from sputum,88.3,80,94,94.3,88.6,97.7,217,Sputum,90,127,https://abbottmolecular.com/home.html
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,RIF resistance from sputum & culture isolates,94,89,99,100,99,100,1008,Sputum; Sputum Culture,NA,NA,https://abbottmolecular.com/home.html
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,INH resistance from sputum & culture isolates,89,86,92,99,98,100,1013,Sputum; Sputum Culture,NA,NA,https://abbottmolecular.com/home.html
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection,94.5,91.7,96.4,94.9,91.1,97.1,596,Sputum,371,225,https://moleculardiagnostics.bd.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF resistance from sputum,100,87.1,100,100,98.2,100,232,Sputum,26,206,https://moleculardiagnostics.bd.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,100,91.8,100,100,98.1,100,242,Sputum,43,199,https://moleculardiagnostics.bd.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,INH detection from sputum,82,63,92,100,98,100,232,Sputum,NA,NA,https://moleculardiagnostics.bd.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,93,89,96,97,96,98,892,Sputum,NA,NA,https://moleculardiagnostics.bd.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,RIF detection from sputum,90,55,100,95,91,97,232,Sputum,NA,NA,https://moleculardiagnostics.bd.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Urine,NA,a2r69000007lbEs,AccuPower TB&MDR RealTime PCR kit-A,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,fabG1; inhA; katG; oxyR-ahpC intergenic region; rpoB,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://bioneer.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Amikacin; Fluoroquinolone; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,a2r69000007lbF4,AccuPower XDR-TB RealTime PCR kit-A,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,gyrA; gyrB; rrs,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://bioneer.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Ethambutol; Streptomycin,NA,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,a2r69000007lbF5,AccuPower XDR-TB RealTime PCR kit-B,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,embB; rpsL,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://bioneer.com
Latent,Triage/Screening,ID,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Other,injection under skin,a2r69000007lbFM,Cy-Tb skin test,Serum Institute of India,India,South-East Asian Region,Regulatory Achieved,WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Host Immune Response,Other,No instrumentation is required,True Point of Care,Colorimetric,Not applicable,Injectable,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://seruminstitute.com
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbLA,Standard F TB LAM Ag FIA,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://sdbiosensor.com
Active,Triage/Screening,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbFJ,FLOW TB Urine LAM Assay,Salus Discovery,United States,Region of the Americas,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://salusd.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,NA,a2r69000006Skdn,Wantai TB-IGRA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",China,Western Pacific Region,Regulatory Achieved,China NMPA; WHO recommended,NA,Mycobacterium Tuberculosis,NA,Immunoassay,ELISA/EIA; IGRA,IA Reagent Kit,Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,NA,0,0,https://ystwt.cn
Active,Triage/Screening,ID,Antibody (serological),MTB IgG; MTB IgM,Not applicable,NA,Plasma; Serum; Whole Blood,NA,a2r69000007lbLH,NOVA Test Tuberculosis IGG/IGM Tri-line Test,"Atlas Link Technology Co., Ltd.",China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://atlas-link.com
Active,Triage/Screening,ID,Antibody (serological),Unknown,Not applicable,NA,Serum,NA,a2r69000007lbLI,NOVA Test Tuberculosis Antibody Test,"Atlas Link Technology Co., Ltd.",China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://atlas-link.com
Latent,Triage/Screening,ID,Antigen,PPD tuberculin,Not applicable,NA,Other,injection under skin,a2r69000007lbLK,Recombinant mycobacterium tuberculosis fusion protein(EC)n,Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.,China,Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Host Immune Response,Other,No instrumentation is required,True Point of Care,Colorimetric,Not applicable,Injectable,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zflongkema.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Cerebrospinal fluid (CSF); Other,Pleural fluid; Pericardial fluid; Peritoneal fluid;,a2r69000007lbLL,IRISA-TB,Antrum Biotech,South Africa,African Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,120,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://antrumbiotech.co
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Rifampicin,NA,Sputum; Sputum Culture,NA,a2r69000007lb6F,MeltPro MTB/RIF Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,rpoB,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Amikacin; Capreomycin; Kanamycin,NA,Sputum; Sputum Culture,NA,a2r69000007lb6B,MeltPro MTB/SL Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,eis promoter; rrs,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Isoniazid,NA,Sputum; Sputum Culture,NA,a2r69000007lb6H,MeltPro MTB/INH Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,inhA; inhA promoter; oxyR-ahpC intergenic region,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Streptomycin,NA,Sputum; Sputum Culture,NA,a2r69000007lb6G,MeltPro MTB/STR Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,rpsL,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Fluoroquinolone,NA,Sputum; Sputum Culture,NA,a2r69000007lb6J,MeltPro MTB/FQ Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,gyrA,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Ethambutol,NA,Sputum; Sputum Culture,NA,a2r69000007lb6I,MeltPro MTB/EMB Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,embB,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB ITS,Not applicable,NA,Sputum; Sputum Culture,NA,a2r69000007lbFP,MeltPro Mycobacteria Identification Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110,Not applicable,NA,Bronchoalveolar lavage; Sputum,NA,a2r69000007lbFO,MeltPro TB Assay,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Active,Diagnostic/confirmatory test,ID,DNA,Other,Not applicable,NA,Sputum; Sputum Culture,NA,a2r69000007lbFQ,MeltPro Mycobacterium Tuberculosis McSpoligotyping Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://zeesandx.com
Latent,Triage/Screening,ID,RNA,Interferon Gamma; Other,Not applicable,NA,Purified RNA,NA,a2r69000007lb8t,T-Track TB part 2 - T-Track TB Quant PCR,Mikrogen GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (open source),A proprietary/new instrument is optional,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,180,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://mikrogen.de
Active,"Monitoring (treatment, immune status, patient)",Host Response,RNA,Unknown,Not applicable,NA,Whole Blood,NA,a2r69000007lb8w,TB22 signature in-house assay,Research Center Borstel,Germany,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Unspecified,Unknown,Lab-based,Fluorescence,Not applicable,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://fz-borstel.de/index.php/en
Active,"Monitoring (treatment, immune status, patient)",Host Response,RNA,Unknown,Not applicable,NA,Finger prick blood,NA,a2r69000007lb8z,RISK 6 host response assay,QuantuMDx Group Limited,United Kingdom,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Unspecified,Unknown,Lab-based,Fluorescence,Not applicable,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://quantumdx.com
Latent,Triage/Screening,ID,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Whole Blood,Blood stimulation tubes,a2r69000007lbEy,T-Track TB part 1 - T-Track TB Stimulation,Mikrogen GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Other,Other,A proprietary/new instrument is optional,Lab-based,Fluorescence,Not applicable,Stimulation/incubation,Manual,Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://mikrogen.de
Active,Triage/Screening,ID,DNA,MTB IS6110,Not applicable,NA,Saliva; Urine,NA,a2r69000007lbL8,RidTB,GenEndeavor llc,United States,Region of the Americas,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Other,Rapid diagnostic test (strip or cassette),Standard lab instrumentation is required,near Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://Genendeavor.com
Active,Triage/Screening,ID,Antigen,Other,Not applicable,NA,Other,Heamolysate,a2r69000007lb8p,Erythra-TB-KIT,Erythra Inc.,China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,near Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,5,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,http://www.genenexus.com/
Active,Diagnostic/confirmatory test,ID,DNA,MTB gyrB Gene; Other,Not applicable,NA,Sputum,NA,a2r69000007lb8j,Loopamp MTBC Detection Kit,"Eiken Chemical Co., Ltd.",Japan,Western Pacific Region,Regulatory Achieved,CE-IVDR; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Isothermal LAMP,NAT reagent kit (open source),Standard lab instrumentation is required,near Point of Care,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,40,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://eiken.co.jp
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110,Not applicable,NA,Sputum; Sputum Culture; Other,EPTB specimen,a2r69000007lbEz,Mylab PathoDetect MTB Detection kit,Mylab Discovery Solutions Pvt. Ltd.,India,South-East Asian Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Unknown,Intended for professional use only,80,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://mylabglobal.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,EPTB specimen,a2r69000007lbF0,Mylab PathoDetect MTB RIF and INH resistance detection kit,Mylab Discovery Solutions Pvt. Ltd.,India,South-East Asian Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,Unknown,NA,Unknown,Intended for professional use only,80,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://mylabglobal.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Bedaquiline,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb68,Truenat MTB-BDQ,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,atpE,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Fluoroquinolone,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb67,Truenat MTB-FQ,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,gyrA,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://molbiodiagnostics.com
Active,"Monitoring (treatment, immune status, patient)",ID,Antigen,Other,Not applicable,NA,Whole Blood,NA,a2r69000007lbL5,T cell activation marker (TAM-TB) assay,Beckman Coulter Inc.,United States,Region of the Americas,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Flow Cytometry,Other,A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,Flow cytometry,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://beckmancoulter.com
Active,"Triage/Screening; Monitoring (treatment, immune status, patient)",ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Sputum,NA,a2r69000007lbL9,PATHFAST-LAM,LSI Medience Corporation,Japan,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://medience.co.jp
Active,Triage/Screening,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbLE,gLAMexpress,Mologic Ltd.,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://mologic.co.uk
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1245; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000007lbEn,TruArray MDR-TB,"Akonni Biosystems, Inc.",United States,Region of the Americas,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://akonni.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Rifampicin,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb6D,Truenat MTB-RIF Dx,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection from sputum,84.2,62.4,94.5,95.2,90.8,97.5,0,Sputum,0,0,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Rifampicin,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb6D,Truenat MTB-RIF Dx,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,84,62,95,95,91,98,186,Sputum,19,167,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from pulmonary and EPTB specimen,91.1,0,0,100,0,0,226,Sputum,191,35,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,73,68,78,98,97,99,1336,Sputum,258,1078,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear positive),91,86,94,NA,NA,NA,174,Sputum,174,0,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection  from sputum (smear negative),37,27,48,98,97,99,1162,Sputum,84,1078,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Isoniazid,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb6E,Truenat MTB-INH,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,inhA; katG,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,100,0,0,96.15,0,0,50,Sputum,0,0,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,79.8,74.5,84.3,96.5,95.2,97.4,1654,Sputum,0,0,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,80,75,84,96,95,97,1336,Sputum,258,1078,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear positive),96,92,98,NA,NA,NA,174,Sputum,174,0,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear negative),46,36,57,97,95,97,1162,Sputum,84,1078,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,a2r69000007lbF9,MDR/MTB ELITe MGB Kit for InGenius platform,ELITechGroup,France,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD,NA,Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://elitechgroup.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110,Not applicable,NA,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,a2r69000007lbFA,MTB EXTRA ELITe MGB Kit for InGenius platform,ELITechGroup,France,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD,NA,Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://elitechgroup.com
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Pyrazinamide,NA,Sputum; Other,Culture,a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,pncA,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,PZA detection from sputum culture,81.2,75.4,85.8,97.8,96.5,98.6,964,Sputum Culture,NA,NA,https://nipro.co.jp
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Pyrazinamide,NA,Sputum; Other,Culture,a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,pncA,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,PZA detection from sputum culture,96.4,93.3,98.4,100,99.4,100,NA,Sputum Culture,NA,NA,https://nipro.co.jp
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Pyrazinamide,NA,Sputum; Other,Culture,a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,pncA,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,PZA detection from sputum culture,95.7,93.5,97.2,98.6,97.4,99.2,NA,Sputum Culture,NA,NA,https://nipro.co.jp
Active,Diagnostic/confirmatory test,Prediction AST,DNA,Not applicable,Fluoroquinolone; Kanamycin,NA,Sputum; Other,Culture,a2r69000007lbll,Genoscholar FQ+KM-TB II,Nipro Corporation,Japan,Western Pacific Region,Research Use Only (RUO),Unknown,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://nipro.co.jp
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,NA,75,100,NA,96.5,100,NA,Sputum,NA,NA,https://nipro.co.jp
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,INH detection from sputum,NA,50,94.9,NA,96.5,97.8,NA,Sputum,NA,NA,https://nipro.co.jp
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,RIF detection from culture isolates,NA,92.8,98.9,NA,97.3,98.2,NA,Sputum Culture,NA,NA,https://nipro.co.jp
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,INH detection from culture isolates,NA,61.6,91.6,NA,99.4,100,NA,Sputum Culture,NA,NA,https://nipro.co.jp
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb6A,cobas MTB-RIF/INH,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection from sputum,96.7,91.7,99.1,97.9,95.8,99.2,NA,Sputum,NA,NA,https://molecular.roche.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb6A,cobas MTB-RIF/INH,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,97.4,93.5,99.3,99.3,97.6,99.9,NA,Sputum,NA,NA,https://molecular.roche.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Plasma,Li-Heprin,a2r69000007lb93,ichroma IGRA-TB 25,Boditech Med Inc.,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Lateral Flow Assay; IGRA,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://boditech.co.kr/en
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000007lbFK,STANDARD M MDR-TB,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,inhA; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,30,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://sdbiosensor.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Plasma,sensitized whole blood in TB-Feron Tubes,a2r69000007lbLC,STANDARD F TB-Feron FIA,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Lateral Flow Assay; IGRA,Rapid diagnostic test (strip or cassette),A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://sdbiosensor.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS1081; MTB IS6110,Not applicable,NA,Unknown,NA,a2r69000007lbLB,STANDARD M MTB/NTM,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://sdbiosensor.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Unknown,Rifampicin,NA,Sputum,NA,a2r69000007lbF2,Gendrive MTB/RIF ID,Epistem Limited,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Unknown,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://epistem.co.uk
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Unknown,Amikacin; Capreomycin; Fluoroquinolone; Kanamycin,NA,Unknown,NA,a2r69000007lb8x,STANDARD M XDR-TB,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Unknown,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://sdbiosensor.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,NA,a2r69000007lbL6,VIDAS TB-IGRA,bioMérieux,France,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Other,A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,Reagent strip,Automated (excluding sample preparation),Intended for professional use only,1020,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://biomerieux-diagnostics.com
Latent,"Monitoring (treatment, immune status, patient)",Host Response,RNA,Other,Not applicable,NA,Whole Blood,NA,a2r69000007lbL7,ISIT-TB,bioMérieux,France,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Unknown,Intended for professional use only,60,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://biomerieux-diagnostics.com
Active,Triage/Screening,ID,Antigen,MTB CFP-10,Not applicable,NA,Serum,NA,a2r69000007lbFC,Nanodisk-MS2,NanoPin Technologies,United States,Region of the Americas,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Mass spectrometry,Laboratory-developed test (LDT),Standard lab instrumentation is required,Lab-based,Unspecified,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://nanopintech.com
Active,Triage/Screening,ID,DNA,Unknown,Not applicable,NA,Other,tongue,a2r69000007lbAY,LumiraDx MTB qSTAR Test,LumiraDx Limited,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,2023,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Electrochemical,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://lumiradx.com/us-en/what-we-do/diagnostics/fast-lab-solutions
Active,Triage/Screening,ID,Antigen,Other,Not applicable,NA,Whole Blood,NA,a2r69000007lbLG,Simoa SR-X,Quanterix,United States,Region of the Americas,Early Stage Development (partial prototype),Unknown,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Other,Unspecified,A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://quanterix.com
Active,"Monitoring (treatment, immune status, patient)",Host Response,RNA,MTB DUSP3; MTB GBP5; MTB KLF2,Not applicable,NA,Whole Blood,NA,a2r69000007lb97,Xpert MTB Host Response assay,Cepheid,United States,Region of the Americas,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://cepheid.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,Blood stimulation tubes,a2r69000007lbFF,QuantiFERON-TB Gold Plus (QFT-Plus),QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; China NMPA; US FDA PMA; WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://www.qiagen.com
Active,Triage/Screening,ID,Antibody (serological),Unknown,Not applicable,NA,Whole Blood,NA,a2r69000007lb8u,MARTI point-of-care TB diagnostic test,MARTI TB Diagnostics (Pty) Ltd,South Africa,African Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Other,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Electrochemical,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://martidiagnostic.com
Active,Diagnostic/confirmatory test,ID,DNA,Unknown,Not applicable,NA,Unknown,NA,a2r69000007lb90,Q-POC - TB Assay,QuantuMDx Group Limited,United Kingdom,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://quantumdx.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,SLID resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,SLID detection from  culture (indirect),76.5,63.3,86,99.1,97.3,99.7,1921,Sputum Culture,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,SLID resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,SLID detection from sputum (direct),87,38.1,98.6,99.5,93.6,100,1639,Sputum,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,FLQ detection from culture (indirect),85.6,79.2,90.4,98.5,95.7,99.5,2233,Sputum Culture,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,FLQ detection from sputum (direct),86.2,74.6,93,98.6,96.9,99.4,1771,Sputum,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,XDR-TB resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,XDR-TB detection from culture (indirect),70.9,42.9,88.8,98.8,96.1,99.6,880,Sputum Culture,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,XDR-TB resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,XDR-TB detection from sputum (direct),69.4,38.8,89,99.4,95,99.3,1420,Sputum,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Other,Independent,TB Detection,0,0,0,0,0,0,0,Sputum,0,0,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Other,Independent,Fluoroquinolone resistance,0,0,0,0,0,0,0,Sputum,0,0,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,SLID resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Other,Independent,SLID resistance,0,0,0,0,0,0,0,Sputum,0,0,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,98.8,0,0,89.6,0,0,331,Sputum,259,72,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,FLQ detection from sputum,93.1,0,0,100,0,0,251,Sputum,54,197,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,AMK detection from sputum,94.7,0,0,98.1,0,0,251,Sputum,40,211,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,CAP detection from sputum,90,0,0,98.1,0,0,251,Sputum,40,211,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,KAN detection from sputum,94.8,0,0,96.6,0,0,251,Sputum,79,172,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Amikacin; Ethambutol; Fluoroquinolone; Linezolid,NA,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,a2r69000007lb8q,LiquidArray MTB-XDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,embB; gyrA; gyrB; rplC; rrl; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://hain-lifescience.de/en/
Latent,Triage/Screening,ID,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Whole Blood,NA,a2r69000007lbFG,LIAISON QuantiFERON-TB Gold Plus assay,QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; US FDA PMA,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),A proprietary/new instrument is required,Lab-based,Colorimetric,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://www.qiagen.com
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,NA,a2r69000007lbLF,QIAReach QuantiFERON-TB,QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Lateral Flow Assay; IGRA,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://www.qiagen.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB 16S rRNA; Other,Not applicable,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lbFI,cobas MTB,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,98.9,96.9,99.7,98.2,96.1,99.3,NA,Sputum,NA,NA,https://molecular.roche.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB 16S rRNA; Other,Not applicable,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lbFI,cobas MTB,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,98.9,96.9,99.7,98.2,96.1,99.3,0,Sputum,0,0,https://molecular.roche.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,95.8,92.6,97.6,98.4,96.9,99.2,NA,Sputum,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,INH detection from sputum,94.5,91.4,96.5,99.3,92.6,100,NA,Sputum,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,RIF detection from culture isolates,91.3,86,95,98,94.3,98.7,NA,Sputum Culture,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,INH detection from culture isolates,89.4,84.3,93.3,98.9,96,99.9,NA,Sputum Culture,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS6110,Not applicable,NA,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,a2r69000007lbF1,FluoroType Mycobacteria VER 1.0 PCR Kit,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://hain-lifescience.de/en/
Latent,Triage/Screening,ID,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Other,injection under skin,a2r69000007lbF3,Diaskintest,Generium,Russian Federation,European Region,Regulatory Achieved,WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Host Immune Response,Other,No instrumentation is required,True Point of Care,Colorimetric,Not applicable,Injectable,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://generium.ru/en
Active,Triage/Screening,ID,Antigen,Unknown,Not applicable,NA,Finger prick blood,NA,a2r69000007lbEw,TB Triage multiplex LFA,Leiden Unversity Medical Center,Netherlands,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,near Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://lumc.nl
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,Blood stimulation tubes,a2r69000007lbEx,LIOFeron TB/LTBI IGRA; HUMAN IFN-g ELISA KIT,LIONEX Diagnostics & Therapeutics GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://lionex.de
Latent,Triage/Screening,ID,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,heprin,a2r69000007lb8v,AdvanSure TB-IGRA ELISA,LG Chem Life Sciences Company,United States,Region of the Americas,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://innovation.lgchem.com
Active,"Monitoring (treatment, immune status, patient)",ID,RNA,MTB 23S rRNA,Not applicable,NA,Sputum,NA,a2r69000007lb8s,TB-MBLA,LifeArc,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,2023,Molecular,qPCR,NAT reagent kit (open source),Standard lab instrumentation is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,300,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://lifearc.org
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Unknown,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000007lbF7,Genechip MDR kit,CapitalBio Technology,China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Other,Cartridge-based processing,A proprietary/new instrument is required,Lab-based,Fluorescence,inhA; katG; rpoB,microarray chip based,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://capitalbiotech.com/en/index.html
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB H37Rv gene,Ethambutol; Fluoroquinolone; Isoniazid; Rifampicin; Streptomycin,NA,Sputum,NA,a2r69000007lbEp,Mycobacterium Tuberculosis and Drug Resistance Gene Rapid NAT Test Kit,"Bao Ruiyuan Biotech(Beijing) Co.,ltd.",China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,embB; gyrA; gyrB; inhA; katG; rpoB; rpsL,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,https://abiores.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110,NA,NA,Sputum,NA,a2r69000009kS4Z,FluoroType MTB VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,NA,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,92.1,87.6,93.3,98.9,64,99.9,2660,Sputum,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kS4e,FluoroType MTBDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,NA,91,96,100,97,100,782,Sputum,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kS4e,FluoroType MTBDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,RIF detection from sputum & culture isolates,NA,97,99,100,85,100,231,Sputum; Sputum Culture,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kS4e,FluoroType MTBDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,INH detection from sputum & culture isolates,NA,70,92,100,84,100,207,Sputum; Sputum Culture,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb95,Xpert MTB/RIF Ultra,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://cepheid.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,a2r69000007lbEu,FluoroType MTBDR VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110,NA,NA,Sputum,NA,a2r69000009kS45,FluoroType MTB VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,NA,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://hain-lifescience.de/en/
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000009kSiA,High sensitive LAM,Abbott Rapid Diagnostics,Germany,European Region,Late Stage Development (fully functional prototype),NA,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Unspecified Market Entry,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Unspecified,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://globalpointofcare.abbott/en/index.html
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000009kSec,TB LAM urine LFA,Biopromic AB,Sweden,European Region,Late Stage Development (fully functional prototype),NA,NA,Mycobacterium Tuberculosis,Unspecified Market Entry,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://biopromic.com
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000009kSeX,Fujifilm SILVAMP TB LAM,FUJIFILM Corporation,Japan,Western Pacific Region,Validation,NA,NA,Mycobacterium Tuberculosis,Unspecified Market Entry,Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://fujifilm.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,MTB ITS,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kSdZ,mfloDx MDR-TB kit,EMPE Diagnostics,Sweden,European Region,Regulatory Status Unknown,None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,PCR (conventional); Lateral Flow Assay,Rapid diagnostic test (strip or cassette),Standard lab instrumentation is required,near Point of Care,Colorimetric,inhA; katG; rpoB,NA,Manual,Intended for professional use only,180,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://empediagnostics.com
Active,Diagnostic/confirmatory test,ID,DNA,NA,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000009kShb,Truenat Ultima,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,NA,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://molbiodiagnostics.com
Active,Diagnostic/confirmatory test,ID,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000009kShW,AIMLAM,"Leide Biosciences Co. , Ltd.",China,Western Pacific Region,Regulatory Status Unknown,NA,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://leidebio.com
Active,Diagnostic/confirmatory test,ID-Prediction AST,DNA,Unknown,Rifampicin,NA,Sputum,NA,a2r69000009kSiF,MultNAT MTB/RIF,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Unspecified Market Entry,Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://en.bioustar.com
Active,Diagnostic/confirmatory test,ID,DNA,Unknown,Not applicable,NA,Other,Tongue swab,a2r69000009kSiB,PortNAT MTB,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Unspecified Market Entry,Molecular,Isothermal NAT(other); Lateral Flow Assay,Cartridge-based processing,No instrumentation is required,True Point of Care,Unspecified,NA,NA,Manual,Intended for professional use only,30,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://en.bioustar.com
Active,Diagnostic/confirmatory test,ID,DNA,MTB IS6110,Not applicable,NA,Bronchoalveolar lavage; Sputum; Urine,NA,a2r69000009kSi0,EasyNAT MTC,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Isothermal NAT(other),Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,65,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,https://en.bioustar.com
